Key facts
- This page summarizes Christopher Yea's Form 4 filing for KalVista Pharmaceuticals, Inc. (KALV).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 24 May 2024, 16:10.
Christopher Yea - 22 May 2024 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)
- Reporting relationship
- CHIEF DEVELOPMENT OFFICER
- Issuer ticker
- KALV
- Reported as of
- 22 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 May 2024, 16:10:04 UTC
- Prior SEC filing
- 21 May 2024
- Next SEC filing
- 21 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Benjamin L. Palleiko, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher Yea filed Form 4 for KalVista Pharmaceuticals, Inc. (KALV) on 24 May 2024.
Change
- Previous filing in this sequence was filed on 21 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KALV
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +50,000
- Change %
- Price
- $0.000000
- Shares after
- 50,000
- Date
- 22 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
Footnote F2
1/16th of the total RSUs subject to the Award shall vest on each quarterly anniversary of the vesting commencement date, commencing on August 22, 2024, until fully vested, subject to continued service through each vesting date.